Trace Wealth Advisors LLC lifted its stake in Procter & Gamble Company (The) (NYSE:PG - Free Report) by 25.5% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 40,750 shares of the company's stock after buying an additional 8,285 shares during the period. Procter & Gamble makes up 6.2% of Trace Wealth Advisors LLC's portfolio, making the stock its 6th biggest position. Trace Wealth Advisors LLC's holdings in Procter & Gamble were worth $6,945,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other institutional investors and hedge funds also recently modified their holdings of PG. Nuveen LLC purchased a new stake in shares of Procter & Gamble in the first quarter worth about $1,954,941,000. GAMMA Investing LLC lifted its stake in shares of Procter & Gamble by 20,758.5% in the first quarter. GAMMA Investing LLC now owns 7,951,456 shares of the company's stock worth $1,355,087,000 after acquiring an additional 7,913,335 shares in the last quarter. Price T Rowe Associates Inc. MD lifted its stake in shares of Procter & Gamble by 13.0% in the first quarter. Price T Rowe Associates Inc. MD now owns 21,480,670 shares of the company's stock worth $3,660,737,000 after acquiring an additional 2,466,308 shares in the last quarter. Invesco Ltd. lifted its stake in shares of Procter & Gamble by 19.8% in the first quarter. Invesco Ltd. now owns 13,493,604 shares of the company's stock worth $2,299,580,000 after acquiring an additional 2,228,151 shares in the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its stake in shares of Procter & Gamble by 15.8% in the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 16,274,563 shares of the company's stock worth $2,728,430,000 after acquiring an additional 2,224,912 shares in the last quarter. Hedge funds and other institutional investors own 65.77% of the company's stock.
Wall Street Analysts Forecast Growth
Several research firms recently commented on PG. UBS Group set a $180.00 price target on Procter & Gamble and gave the stock a "buy" rating in a research note on Wednesday, July 30th. Wells Fargo & Company cut their price target on Procter & Gamble from $175.00 to $173.00 and set an "overweight" rating on the stock in a research note on Wednesday, July 30th. Barclays set a $164.00 price target on Procter & Gamble and gave the stock an "equal weight" rating in a research note on Thursday, July 31st. Evercore ISI reiterated an "in-line" rating and issued a $170.00 price target (down previously from $190.00) on shares of Procter & Gamble in a research note on Monday, July 14th. Finally, Piper Sandler boosted their price target on Procter & Gamble from $160.00 to $164.00 and gave the stock a "neutral" rating in a research note on Monday, May 5th. One investment analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating and seven have issued a Hold rating to the stock. According to data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average price target of $175.12.
Read Our Latest Report on Procter & Gamble
Insider Activity at Procter & Gamble
In other news, CEO Gary A. Coombe sold 10,194 shares of the company's stock in a transaction that occurred on Thursday, August 21st. The stock was sold at an average price of $158.16, for a total transaction of $1,612,283.04. Following the completion of the transaction, the chief executive officer directly owned 34,978 shares of the company's stock, valued at approximately $5,532,120.48. This represents a 22.57% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Andre Schulten sold 11,638 shares of the company's stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of $157.27, for a total value of $1,830,308.26. Following the transaction, the chief financial officer directly owned 52,642 shares of the company's stock, valued at $8,279,007.34. This trade represents a 18.11% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 120,181 shares of company stock valued at $18,918,012. 0.18% of the stock is owned by insiders.
Procter & Gamble Trading Up 1.0%
Shares of NYSE PG opened at $157.13 on Friday. The stock's 50 day moving average price is $156.55 and its two-hundred day moving average price is $162.50. Procter & Gamble Company has a 52-week low of $149.91 and a 52-week high of $180.43. The stock has a market capitalization of $368.07 billion, a P/E ratio of 24.14, a PEG ratio of 4.14 and a beta of 0.37. The company has a quick ratio of 0.49, a current ratio of 0.70 and a debt-to-equity ratio of 0.49.
Procter & Gamble (NYSE:PG - Get Free Report) last announced its quarterly earnings data on Tuesday, July 29th. The company reported $1.48 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.42 by $0.06. Procter & Gamble had a return on equity of 32.69% and a net margin of 18.95%.The firm had revenue of $20.89 billion for the quarter, compared to analysts' expectations of $20.79 billion. During the same quarter in the prior year, the firm posted $1.40 earnings per share. Procter & Gamble's revenue for the quarter was up 1.7% compared to the same quarter last year. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. On average, analysts anticipate that Procter & Gamble Company will post 6.91 earnings per share for the current fiscal year.
Procter & Gamble Announces Dividend
The business also recently announced a quarterly dividend, which was paid on Friday, August 15th. Stockholders of record on Friday, July 18th were issued a dividend of $1.0568 per share. The ex-dividend date of this dividend was Friday, July 18th. This represents a $4.23 annualized dividend and a dividend yield of 2.7%. Procter & Gamble's dividend payout ratio is 64.98%.
About Procter & Gamble
(
Free Report)
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report